CSPC Pharmaceutical Group... (CHJTF)

PNK: CHJTF · Real-Time Price · USD

0.64

0.02 (3.23%)

At close: May 01, 2025, 8:00 PM

CSPC Pharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	6.78B	12.02B	11.56B	11.36B	8.65B	4.82B	4.33B	4.38B	2.9B
Short-Term Investments	1.47B	1.08B	4.01B	1.77B	1.82B	2.06B	2.29B	1.1B	466.5K
Long-Term Investments	4.8B	5.13B	4.25B	4.42B	4.66B	1.83B	-1.39B	-743.52M	153.38M
Other Long-Term Assets	1.53B	264.66M	630.6M	513.63M	421.34M	172.73M	2.62B	1.1B	466.51K
Receivables	9.94B	10.13B	7.62B	7.98B	5.78B	4.92B	13.14M	2.58M	2.77B
Inventory	3.13B	3.14B	2.87B	3.03B	2.21B	2.84B	3.04B	2.42B	1.73B
Other Current Assets	362.35M	n/a	6.84B	6.55B	415.06M	4.64B	4.11B	3.48B	337.53M
Total Current Assets	21.89B	26.74B	26.9B	24.88B	18.88B	15.32B	13.78B	11.39B	7.55B
Property-Plant & Equipment	13.08B	13.5B	12.32B	11.7B	10.59B	10.38B	7.2B	6.05B	5.32B
Goodwill & Intangibles	2.84B	2.43B	2.67B	939.25M	958.84M	1.69B	945.86M	187.94M	171.04M
Total Long-Term Assets	22.5B	21.51B	20B	17.62B	16.78B	14.12B	9.39B	6.61B	5.67B
Total Assets	44.39B	46.28B	46.9B	42.5B	35.65B	29.44B	22.69B	18B	13.22B
Account Payables	2.61B	2.84B	2.01B	1.62B	1.24B	1.43B	3.27B	1.3B	1.09B
Deferred Revenue	n/a	-8.31M	897.58M	524.05M	741.85M	563.5M	795.54M	1.00	1.00
Short-Term Debt	392.2M	450.22M	331.83M	n/a	265.39M	23M	70.59M	927.28M	897.78M
Other Current Liabilities	945.86M	827.12M	1.86B	645.75M	1.75B	1.45B	3.91B	2.59B	2.1B
Total Current Liabilities	9.63B	10.18B	10.06B	8.84B	7.47B	6.98B	7.23B	4.81B	3.66B
Long-Term Debt	n/a	n/a	28.95M	n/a	92.88M	n/a	n/a	50M	215.24M
Other Long-Term Liabilities	407.81M	399.68M	76.35M	12.42M	-75.64M	62.39M	201.9M	153.71M	156.66M
Total Long-Term Liabilities	888.67M	1.08B	1.01B	534.69M	490.05M	457.11M	439.35M	313.68M	433.56M
Total Liabilities	10.52B	11.26B	11.07B	9.37B	7.96B	7.43B	7.67B	5.13B	4.09B
Total Debt	507.33M	706.9M	654.05M	115.04M	375.51M	209.78M	70.45M	824.82M	1.02B
Common Stock	11.03B	12B	12.24B	13.33B	12.92B	12.19B	11.35B	10.8B	9.46B
Retained Earnings	23.34B	28.87B	23.73B	21.13B	15.79B	10.86B	9.37B	7.04B	5.27B
Comprehensive Income	n/a	-7.46B	-1.97B	-2.57B	-2.12B	-2.28B	-2.8B	-2.3B	-1.88B
Shareholders Equity	32.26B	33.2B	33.9B	31.79B	26.48B	20.65B	15.02B	12.8B	9.05B
Total Investments	6.27B	6.31B	8.26B	6.18B	6.48B	3.89B	896.76M	356.57M	153.85M